Back

The prevalence of transthyretin amyloidosis in patients with heart failure with preserved ejection fraction

22 May 2023 (11:00 - 11:45)
Organised by: Logo
Congress Presentation Part of: Myocardial disease - clinical 3 Clinical HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Associate Professor Jaewon Oh

Yonsei University, Seoul (Korea (Republic of))

6 More presentations in this session

Presentation thumbnail
The T-Amylo score facilitates the diagnostic approach of transthyrretin cardiac amyloidosis
Doctor C. Goena Vives (Donostia, ES)
Abstract Slides
Presentation thumbnail
Parvovirus B19 myocarditis: The utility of viral load assessment in determining the significance of a virus positive biopsy in South Africa
Doctor K. Hassan (Mossel Bay, ZA)
Abstract Slides
Presentation thumbnail
Takotsubo Syndrome in patients with history of malignancy: clinical features and follow-up
Doctor A. Pinho (Porto, PT)
Abstract Slides
Presentation thumbnail
What determines the 6-minute walk distance in patients with transthyretin cardiomyopathy?
Mr V. Cejka (Wurzburg, DE)
Abstract Slides
Presentation thumbnail
Cardiac amyloidosis in a tertiary care center in south India - a case series
Doctor A. Jain (Surat, IN)
Abstract Slides

Access the full session

Session thumbnail
Myocardial disease - clinical 3

The Event

Event poster

Heart Failure 2023

22 May 2023 11:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources